TABLE 2.
Related indicators of the sex hormone parameters of the four patients.
| Items | Patient 1 | Patient 2 | Patient 3 | Patient 4 | Clinical |
|---|---|---|---|---|---|
| Prolactin (PRL) | 108 | 468.4 | 66.7 | 6.37 | Follicular stage 66–490 Ovulation period 66–490 Luteal phase 66–490 Menopause 62–410 |
| Follicle oietin (FSH) | 5.71 | 4.286 | 0.167 | 11.09 | Follicular stage 3.2–15 Ovulation period 7.5–20 Luteal phase 1.3–11 Menopause 36–138 |
| Luteinizing hormone (LH) | 5.98 | 4.764 | <0.1 | 0.77 | Follicular stage 1.2–12.5 Ovulation period 12–82 Luteal phase 0.4–19 Menopause 14–48 |
| Progesterone | 1.03 | 0.454 | 1.122 | 3.27 | Follicular stage 0.4–2.3 Luteal phase 1.2–18.8 Menopause 0–1.4 |
| Testosterone (TEST) | 2,67 | 1.055 | 1.228 | 3.5 | Follicular stage 0–1.0 Ovulation period 0–1.0 Luteal phase 0–1.0 Menopause 0–1.0 |
Note: All four patients had normal prolactin. Unit (mIU/mL). These four patients had normal FSH, LH, and progesterone. The patient 1, 2, and 3 had normal androgen and the fourth patient had elevated androgen.